Cargando…
Development of interferon γ-based immunocytokines targeting renal cancer
Advanced renal cancer is an incurable malignancy in need of novel therapeutic avenues. We have generated interferon γ (IFNγ)-based fusion antibodies (immunocytokines) that target CD70, a putative biomarker of renal cancer. These immunocytokines efficiently labeled renal cancer cells, and, when combi...
Autores principales: | Chen, Peirong, Balachandran, Siddharth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782162/ https://www.ncbi.nlm.nih.gov/pubmed/24073376 http://dx.doi.org/10.4161/onci.24964 |
Ejemplares similares
-
Anti-CD70 Immunocytokines for Exploitation of Interferon-γ-Induced RIP1-Dependent Necrosis in Renal Cell Carcinoma
por: Chen, Peirong, et al.
Publicado: (2013) -
Antitumor activity of an immunocytokine composed of an anti-GD2 antibody and the IL-15 superagonist RLI
por: Vincent, Marie, et al.
Publicado: (2013) -
Long-lasting antitumor effects provided by radiotherapy combined with the immunocytokine L19-IL2
por: Rekers, Nicolle H, et al.
Publicado: (2015) -
Chronic liver inflammation dominated by interferon-γ can prevent hepatocarcinogenesis
por: Schrader, Jörg, et al.
Publicado: (2012) -
Interferons in hematopoiesis and leukemia
por: Schürch, Christian M, et al.
Publicado: (2013)